Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Nambisan, V.
Right arrow Articles by Chao, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nambisan, V.
Right arrow Articles by Chao, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Dying and defibrillation: a shocking experience

Vinod Nambisan

North Middlesex University Hospital, Sterling Way, London and Marie Curie Hospice, Hampstead (Edenhall), London

David Chao

North Middlesex University Hospital, Sterling Way, London

Palliative Care physicians are frequently involved in the care of patients with significant comorbidity and often have to take coexisting conditions into account when treating patients. An example of an area in which this is particularly relevant and will undoubtedly increase is presented with the case report of a patient with terminal metastatic lung carcinoma and an Implantable Cardioverter Defibrillator (ICD) in place. The role of the ICD in preventing the patient from dying comfortably is discussed, as are means of deactivating the device. We conclude that patients with ICDs and terminal disease should have the issue of deactivation addressed at the earliest possible opportunity as practical difficulties may arise in the emergency setting, especially in the nonhospital environment.

Key Words: Implantable Cardioverter Defibrillator • palliative care • terminal care

Palliative Medicine, Vol. 18, No. 5, 482-483 (2004)
DOI: 10.1191/0269216304pm907cr
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 AM J HOSP PALLIAT CAREHome page
A. S. Kelley, S. S. Mehta, and M. Carrington Reid
Management of Patients with ICDs at the End of Life (EOL): A Qualitative Study
American Journal of Hospice and Palliative Medicine, January 1, 2009; 25(6): 440 - 446.
[Abstract] [PDF]

Home page
 J. Med. EthicsHome page
R. England, T. England, and J. Coggon
The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer
J. Med. Ethics, September 1, 2007; 33(9): 538 - 540.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. T. Berger
The Ethics of Deactivating Implanted Cardioverter Defibrillators
Ann Intern Med, April 19, 2005; 142(8): 631 - 634.
[Abstract] [Full Text] [PDF]